CHRIS VERRICO to Male
This is a "connection" page, showing publications CHRIS VERRICO has written about Male.
Connection Strength
0.369
-
A randomized trial of safety and pharmacodynamic interactions between a selective glucocorticoid receptor antagonist, PT150, and ethanol in healthy volunteers. Sci Rep. 2021 05 10; 11(1):9876.
Score: 0.029
-
Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence. Clin Pharmacol Ther. 2020 12; 108(6):1203-1212.
Score: 0.027
-
Recovery from impaired working memory performance during chronic ?-9-tetrahydrocannabinol administration to adolescent rhesus monkeys. J Psychopharmacol. 2020 02; 34(2):211-220.
Score: 0.026
-
Use of Guanfacine for Cannabis Use Disorder and Related Symptomology. Am J Addict. 2019 11; 28(6):455-464.
Score: 0.026
-
FAAH variant Pro129Thr modulates subjective effects produced by cocaine administration. Am J Addict. 2018 10; 27(7):567-573.
Score: 0.024
-
Guanfacine Attenuates Adverse Effects of Dronabinol (THC) on Working Memory in Adolescent-Onset Heavy Cannabis Users: A Pilot Study. J Neuropsychiatry Clin Neurosci. 2018; 30(1):66-76.
Score: 0.022
-
Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study. Int J Neuropsychopharmacol. 2016 07; 19(7).
Score: 0.021
-
Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. Drug Alcohol Depend. 2014 Aug 01; 141:72-8.
Score: 0.018
-
Repeated ?9-tetrahydrocannabinol exposure in adolescent monkeys: persistent effects selective for spatial working memory. Am J Psychiatry. 2014 Apr; 171(4):416-25.
Score: 0.018
-
Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers. Int J Neuropsychopharmacol. 2014 Feb; 17(2):223-33.
Score: 0.017
-
Delay- and dose-dependent effects of ??-tetrahydrocannabinol administration on spatial and object working memory tasks in adolescent rhesus monkeys. Neuropsychopharmacology. 2012 May; 37(6):1357-66.
Score: 0.015
-
Acquisition and baseline performance of working memory tasks by adolescent rhesus monkeys. Brain Res. 2011 Mar 10; 1378:91-104.
Score: 0.014
-
MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor. J Psychopharmacol. 2008 Mar; 22(2):187-202.
Score: 0.012
-
Is bedtime use of kratom (Mitragyna speciosa) a sleep aid or disruptor? Examining its daily effects and individual differences. Exp Clin Psychopharmacol. 2025 Oct; 33(5):513-522.
Score: 0.010
-
Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention. Neuropsychopharmacology. 2004 Mar; 29(3):522-9.
Score: 0.009
-
Persistent and anatomically selective reduction in prefrontal cortical dopamine metabolism after repeated, intermittent cannabinoid administration to rats. Synapse. 2003 Jul; 49(1):61-6.
Score: 0.008
-
Systemic, but not local, administration of cannabinoid CB1 receptor agonists modulate prefrontal cortical acetylcholine efflux in the rat. Synapse. 2003 Jun 15; 48(4):178-83.
Score: 0.008
-
An Evaluation of Yoga and Meditation to Improve Attention, Hyperactivity, and Stress in High-School Students. J Altern Complement Med. 2020 Aug; 26(8):701-707.
Score: 0.007
-
Rivastigmine does not alter cocaine-induced subjective effects or self-administration. Pharmacol Biochem Behav. 2019 10; 185:172758.
Score: 0.006
-
The prevalence, metabolic disturbances and clinical correlates of recent suicide attempts in Chinese inpatients with major depressive disorder. BMC Psychiatry. 2019 05 10; 19(1):144.
Score: 0.006
-
Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder. Int J Neuropsychopharmacol. 2015 Sep 12; 19(3):pyv098.
Score: 0.005
-
Dopamine D3 receptor-preferring agonist enhances the subjective effects of cocaine in humans. Psychiatry Res. 2015 Nov 30; 230(1):44-9.
Score: 0.005
-
A comparison of impulsivity, depressive symptoms, lifetime stress and sensation seeking in healthy controls versus participants with cocaine or methamphetamine use disorders. J Psychopharmacol. 2015 Jan; 29(1):50-6.
Score: 0.005
-
Short-term, low-dose varenicline administration enhances information processing speed in methamphetamine-dependent users. Neuropharmacology. 2014 Oct; 85:493-8.
Score: 0.004
-
The relationship between sleep and drug use characteristics in participants with cocaine or methamphetamine use disorders. Psychiatry Res. 2014 Oct 30; 219(2):367-71.
Score: 0.004
-
Preliminary findings of the effects of rivastigmine, an acetylcholinesterase inhibitor, on working memory in cocaine-dependent volunteers. Prog Neuropsychopharmacol Biol Psychiatry. 2014 Apr 03; 50:137-42.
Score: 0.004
-
Endocannabinoid metabolism in the prefrontal cortex in schizophrenia. Schizophr Res. 2013 Jun; 147(1):53-57.
Score: 0.004
-
Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology. 2010 Sep; 35(10):2060-71.
Score: 0.003
-
Adaptation of monoaminergic responses to phencyclidine in nucleus accumbens and prefrontal cortex following repeated treatment with fluoxetine or imipramine. Brain Res. 2002 Dec 20; 958(1):20-7.
Score: 0.002
-
Effects of nicotine pretreatment on dopaminergic and behavioral responses to conditioned fear stress in rats: dissociation of biochemical and behavioral effects. Biol Psychiatry. 2001 Feb 01; 49(3):300-6.
Score: 0.002
-
Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization. J Pharmacol Exp Ther. 2000 Oct; 295(1):58-66.
Score: 0.002
-
Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms. Neuropsychopharmacology. 2000 Jul; 23(1):79-88.
Score: 0.002
-
Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats. Neurosci Lett. 1998 Dec 24; 258(3):175-8.
Score: 0.002
-
Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress. Brain Res. 1998 Aug 10; 801(1-2):36-49.
Score: 0.001
-
Repeated exposure to delta 9-tetrahydrocannabinol reduces prefrontal cortical dopamine metabolism in the rat. Neurosci Lett. 1998 May 01; 246(3):169-72.
Score: 0.001
-
Diet-induced changes in serum cholesterol concentrations do not alter tryptophan hydroxylation rate or serotonin concentrations in gerbil brain. Life Sci. 1996; 58(17):1433-44.
Score: 0.001